| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |